Skip to main content
Premium Trial:

Request an Annual Quote

Fool Me Once…

In The Scientist PNNL's Steven Wiley explains why he's sat out the mad rush for Challenge Grants. "Although the intent is good, history suggests that these grants will eventually be looked upon as one of the greatest time wasters of the decade," he writes. In the '90s, he says there was a similar rush for funding from the US Army Breast Cancer Research Program and for that his area of research was only funded at four percent -- "much less than the NIH payline."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.